clinical trial data

The Rising Need for Data on Demand in Clinical Trials

When you speak about data and clinical trials most people think it’s about the data you generate throughout the trial. It’s true that data collection and management of each study are crucial for ensuring the safety of participants but also the information on the endpoints of clinical trials is the real purpose of research. Thankfully …

The Rising Need for Data on Demand in Clinical Trials Read More »

The Past, Present and Future of Public Clinical Trial Registries

In my article on the 3 main limitations to public clinical trial registries, I mentioned that public registries were not designed for the purposes of feasibility. While this is true, the scientific community was intended as one of the beneficiaries of the initiative right from the start.  To understand better why public registries hold back …

The Past, Present and Future of Public Clinical Trial Registries Read More »

This Is How Data Gets in the Way of Clinical Research

For most of you involved with clinical trials, it’s not a secret that clinical research is not about patients, it’s not about a new treatment, it’s all about DATA. Yet, data is what we miss the most and I don’t only mean this in the sense of having access to essential information. What we miss …

This Is How Data Gets in the Way of Clinical Research Read More »

The 3 Main Limitations To Public Clinical Trial Registers (And Why They’re Still The Go-To for Feasibility)

Public clinical trial registers were designed to comply with regulations (and make the public aware of past, ongoing, and future clinical trials), not for the purposes of clinical trial feasibility. This becomes abundantly clear once you try to gather the data you need for site selection or calculate recruitment rate for multiple sites in multiple …

The 3 Main Limitations To Public Clinical Trial Registers (And Why They’re Still The Go-To for Feasibility) Read More »

What Stops Patient Engagement in Clinical Trials

Last week I was invited to speak at Bayer’s Headquarters during their Annual Patient Engagement Meetup. This year I was attending a lot of other similar events thanks to our collaboration with different companies like Boehringer Ingelheim, Merck, Novartis, etc. And the last one really reminded me of: What Stops Patient Engagement in Clinical Research? …

What Stops Patient Engagement in Clinical Trials Read More »

Data sources in Feasibility for clinical trials | Part 2

In my last article about Feasibility, data sources are defined so that you can recognise the best ones and choose which ones to use. To summarise, no matter what data sources you use they should be: Accurate Meaningful All-encompassing   If you want to learn more about this, you can read my previous article: Today …

Data sources in Feasibility for clinical trials | Part 2 Read More »

Data sources in Feasibility for clinical trials? | Part 1

Feasibility for clinical trials is all about finding the right sources of data, being able to analyse them and then make decisions for country selection, sites and investigators, as well as patient recruitment strategies. It sounds simple and yet, when it comes to execution it’s very complicated. Therefore feasibility specialists have a lot of questions …

Data sources in Feasibility for clinical trials? | Part 1 Read More »